Recommendations for the optimal introduction of novel antibiotics to treat uncomplicated gonorrhoea in the face of increasing antimicrobial resistance: a case study with zoliflodacin

Abstract New, first-in-class oral antibiotics like zoliflodacin, developed in a public–private partnership, require an optimal introduction strategy while ensuring antibiotic stewardship. Zoliflodacin, given as a single dose for uncomplicated urogenital gonorrhoea, recently demonstrated non-inferior...

Полное описание

Библиографические подробности

Главные авторы:	Fernando Pascual, Carmen Au, Chido Dziva Chikwari, Pierre Daram, Carolyn Deal, Angelica Espinosa Miranda, Yonatan H. Grad, Edward WIII Hook, Rossaphorn Kittiyaowamarn, Alison Luckey, Nicola Low, Venessa Maseko, Remco P. H. Peters, Teri Roberts, Magnus Unemo, Subasree Srinivasan
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2024-09-01
Серии:	BMC Global and Public Health
Предметы:	Public health Sexually transmitted infections Antimicrobial resistance Neisseria gonorrhoeae Gonorrhoea Health policy
Online-ссылка:	https://doi.org/10.1186/s44263-024-00087-w
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!